-+ 0.00%
-+ 0.00%
-+ 0.00%

Argus Research Downgrades Novo Nordisk to Hold

Benzinga·12/08/2025 13:20:53
Listen to the news
Argus Research analyst John Eade downgrades Novo Nordisk (NYSE:NVO) from Buy to Hold.